Author: Chatziparasidis, Grigorios; Kantar, Ahmad
Title: Calprotectin: An Ignored Biomarker of Neutrophilia in Pediatric Respiratory Diseases Cord-id: k6drj86o Document date: 2021_5_21
ID: k6drj86o
Snippet: Calprotectin (CP) is a non-covalent heterodimer formed by the subunits S100A8 (A8) and S100A9 (A9). When neutrophils become activated, undergo disruption, or die, this abundant cytosolic neutrophil protein is released. By fervently chelating trace metal ions that are essential for bacterial development, CP plays an important role in human innate immunity. It also serves as an alarmin by controlling the inflammatory response after it is released. Extracellular concentrations of CP increase in res
Document: Calprotectin (CP) is a non-covalent heterodimer formed by the subunits S100A8 (A8) and S100A9 (A9). When neutrophils become activated, undergo disruption, or die, this abundant cytosolic neutrophil protein is released. By fervently chelating trace metal ions that are essential for bacterial development, CP plays an important role in human innate immunity. It also serves as an alarmin by controlling the inflammatory response after it is released. Extracellular concentrations of CP increase in response to infection and inflammation, and are used as a biomarker of neutrophil activation in a variety of inflammatory diseases. Although it has been almost 40 years since CP was discovered, its use in daily pediatric practice is still limited. Current evidence suggests that CP could be used as a biomarker in a variety of pediatric respiratory diseases, and could become a valuable key factor in promoting diagnostic and therapeutic capacity. The aim of this study is to re-introduce CP to the medical community and to emphasize its potential role with the hope of integrating it as a useful adjunct, in the practice of pediatric respiratory medicine.
Search related documents:
Co phrase search for related documents- abnormal immune response and acute respiratory infection: 1, 2, 3
- abundant protein and acid glycoprotein: 1
- abundant protein and activation cascade: 1
- abundant protein and activation release: 1
- abundant protein and acute respiratory infection: 1, 2, 3
- acid glycoprotein and activation release: 1
- acid glycoprotein and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acid glycoprotein and acute phase protein: 1, 2, 3, 4, 5, 6, 7, 8
- acid glycoprotein and acute phase response: 1, 2
- acid glycoprotein and acute respiratory infection: 1, 2, 3, 4, 5, 6
- activate tnf and acute respiratory infection: 1
- activation cascade and acute phase: 1, 2, 3
- activation cascade and acute phase protein: 1, 2
- activation cascade and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activation marker and acute phase: 1, 2, 3, 4
- activation marker and acute phase protein: 1, 2
- activation marker and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7
- activation release and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
- activation release and acute phase response: 1, 2
Co phrase search for related documents, hyperlinks ordered by date